ID FDCP Mix A4/LRARa403SN c.4 AC CVCL_D1L4 DR Wikidata; Q127380850 RX Patent=US5830760; RX PubMed=1334022; CC Characteristics: IL3 dependent. CC Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9864; RARA (Note=RARalpha403; truncated version AA 1-403). CC Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. CC Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. CC Breed/subspecies: C57BL/6 x DBA/2. OX NCBI_TaxID=10090; ! Mus musculus (Mouse) HI CVCL_2040 ! FDCP-Mix cl.A4 CA Factor-dependent cell line DT Created: 30-01-24; Last updated: 19-12-24; Version: 3 // RX Patent=US5830760; RA Tsai S., Collins S.J.; RT "Creating novel hematopoietic cell lines by expressing altered RT retinoic acid receptors."; RL Patent number US5830760, 03-Nov-1998. // RX PubMed=1334022; DOI=10.1101/gad.6.12a.2258; RA Tsai S., Bartelmez S.H., Heyman R., Damm K., Evans R., Collins S.J.; RT "A mutated retinoic acid receptor-alpha exhibiting dominant-negative RT activity alters the lineage development of a multipotent RT hematopoietic cell line."; RL Genes Dev. 6:2258-2269(1992). //